ADMA Biologics Inc (ADMA) Just Gave Us A CRL Opportunity

ADMA Biologics Inc (NASDAQ:ADMA) just picked up a complete response letter (CRL) from the FDA, and the company is down more than 31% after hours on Friday.

Keep Reading →